RE:RE:RE:RE:RE:RE:Catching breathMercuryfilling1 wrote: Last January, smart longs got in and out quickly, really quickly, knowing the window of opportunity for large profits was small - everything was based on one patient and the huge swell was obviously going to be momentary, despite the scapegoats (Doug Loe etc.) invoked by some here. Smart longs took profits (massive if their initial costs were between 20 & 30 cents per share) then got back in when the SP drifted down. That didn’t sit well with some folks, it’s as if the original longs had cheated the system somehow! Shouldn’t everyone suffer like the ones who got in above $1.50 ? Well, maybe, but investors like Rix have been onboard for 20+ years (me too, back when Pheromone Sciences ruled the roost) and any huge gains spread over 20 years kind of even out over that span - a good index fund would have given me similar gains. In and out is not a strategy this time ‘round (that’s what she said) because as MS has pointed out (but only after Jwall and others pointed to the link days before) competition is falling by the wayside. Bio has said the future is deviceless but I sense he’s wondering this time around. It feels different and though I intend to divest a healthy portion as the shares surge, the bulk of my holdings will sit tight. Whatever your strategy, I wish us all luck.
Mercury and Red,
I think we are at a critical potential turning point for the company . The past history of the company, with any positive news, was always followed by a cheap " down and dirty " financing. The catalysts of potentially ground breaking news by Witowski followed by a potential pharma deal coupled with the competition faltering changes things dramatically. The fact there are two sets of warrants due this summer that are in the money , will provide sufficient funds to alleviate any fear of a financing. Also might have investors selling to cash in warrants but that timeframe is the summer.
Once this goes on to the Nasdaq , the days of manipulation will be gone . Everybody has their own reasons to exit the investment . I think there will be very few legacy investors left at the end . Look at what happened with Trillium .... it actually traded much higher and was bought out at a much lower share price.
Nobody has a crystal ball, but I would keep a core position and have a position that you trade if that's your thing . Any geopolitical events (war, economic collapse , debt currency crisis) or dramatic correction in the overall market are factors that also must be taken into consideration .
I guess it's a nice problem to have .
Mustang Sally